Patent ID: 6949546
Filing Date: 2005-09-27
Classification: A61P,C07D

Abstract:
1. A compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein: M is absent; Q is selected from CH K is selected from CH L is selected from CHR J is selected from CH Z is selected from O, S, NR R R G is selected from a bond, C═O, and SO Ring B is a 5, 6, or 7 membered saturated heterocyclic ring wherein the heterocycle ring includes —NR R R R R R R R R R R R R R R with the proviso that when any of J or K is CR R R alternatively, R R R R R R R R R R R R R R R R R R R provided that if R R alternatively, R R R R R R R alternatively, R R R R R R R R R R R R R R R′, at each occurrence, is independently selected from H, C R alternatively, R R R R R R R R R R alternatively, R R R R R R R m, at each occurrence, is independently selected from 0, 1, and 2; t, at each occurrence, is independently selected from 1 and 2; w, at each occurrence, is independently selected from 0 and 1; r, at each occurrence, is independently selected from 0, 1, 2, 3, 4, and 5; q, at each occurrence, is independently selected from 1, 2, 3, 4, and 5; and p, at each occurrence, is independently selected from 0, 1, and 2.